share_log

HC Wainwright & Co. Maintains Buy on Mainz Biomed, Raises Price Target to $9

Benzinga ·  Sep 22, 2023 12:57

HC Wainwright & Co. analyst Yi Chen maintains Mainz Biomed (NASDAQ:MYNZ) with a Buy and raises the price target from $7 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment